Leaflet FOSRENOL 1000mg oral powder


Indicated for: hyperphosphatemia

Route of administration: oral

Substance: lanthanum (phosphate binder)

ATC: V03AE03 (Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia)

Lanthanum is a chemical element used in medicine in the form of lanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease. It works by binding phosphates from food in the digestive tract, thereby reducing blood phosphorus levels.

The medication is taken orally, usually during meals, to maximize effectiveness. It is important for patients to follow a low-phosphorus diet during treatment.

Side effects may include nausea, diarrhea, constipation, or abdominal discomfort. In rare cases, allergic reactions or other complications may occur.

Patients should inform their doctor about any other medications they are taking, as drug interactions may occur. Pregnant or breastfeeding women should consult a specialist before use.

General data about FOSRENOL 1000mg

  • Substance: lanthanum
  • Date of last drug list: 01-10-2020
  • Commercial code: W66750001
  • Concentration: 1000mg
  • Pharmaceutical form: oral powder
  • Quantity: 90
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: CATALENT GERMANY SCHORNDORF GMBH - GERMANIA
  • Holder: SHIRE PHARMACEUTICALS IRELAND LIMITED - IRLANDA
  • Number: 7357/2015/01
  • Shelf life: 3 years

Pharmaceutical forms available for lanthanum

Concentrations available for lanthanum

  • 1000mg
  • 250mg
  • 500mg
  • 750mg